Product Information
LARIN 21 1-20 TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1842 per EA under NDC 16714040801. Its NADAC has been published 618 times since Oct 22, 2014.
FDA first approved this application on Dec 4, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
NorthStar Rx LLCNDC
16714040801
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202995FDA Approved
12/4/2013
TE Code
AB
On Market Since
12/4/2013
Price Statistics
The NADAC for LARIN 21 1-20 TABLET has been published 618 times since Oct 22, 2014, and over the history we have for it it has declined 76.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1842 per EA |
|---|---|
| All-time high | $0.8827 (Jan 13, 2016) |
| All-time low | $0.1619 (Nov 20, 2024) |
| 52-week high | $0.1842 |
| 52-week low | $0.1652 |
| Median price | $0.3516 |
| Average price | $0.4105 |
| Largest weekly change | +37.1% (May 22, 2019) |
| Weeks tracked | 618 |
| Tracking since | Oct 22, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LARIN 21 1-20 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LARIN 21 1-20 TABLET, manufactured by NorthStar Rx LLC, is $0.1842 per EA (NDC 16714040801), effective Aug 19, 2026.
How has the price of LARIN 21 1-20 TABLET changed over time?
Over the history we have for it, the NADAC for LARIN 21 1-20 TABLET has declined 76.2%. It has been tracked across 618 weekly CMS publications since Oct 22, 2014.
What are the highest and lowest recorded NADAC prices for LARIN 21 1-20 TABLET?
Since Oct 22, 2014, the NADAC for LARIN 21 1-20 TABLET has ranged from a low of $0.1619 (Nov 20, 2024) to a high of $0.8827 (Jan 13, 2016), with a median of $0.3516 per EA.
Are there cheaper alternatives to LARIN 21 1-20 TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MICROGESTIN 21 1-20 TABLET, is $0.1703 per EA — about 8% below LARIN 21 1-20 TABLET.
Who manufactures LARIN 21 1-20 TABLET?
LARIN 21 1-20 TABLET (NDC 16714040801) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.